EUROPEAN BIOTECHNOLOGY MAGAZINE - For decades, biotech companies were formed around a discovery: a promising biological signal, a novel target, a platform emerging from academic research. Now a different formation model is gaining momentum: venture studios. These entities don't just fund startups, they assemble them, testing hypotheses, building...

EU PERSPECTIVES - Europe is preparing to combine its flu and COVID-19 vaccines into a single seasonal shot. But the more pressing problem is not scientific — it is whether anyone will actually get vaccinated. Across the EU, uptake among the most at-risk has collapsed, and the systems meant to fix that are not keeping pace. Read more

EU PERSPECTIVES - France's president called a global health summit — and used it to declare that global cooperation is breaking down. Emmanuel Macron, hosting world leaders in Lyon under France's G7 presidency, championed the "One Health" approach, which treats human, animal and ecosystem health as inseparable. But his core message was a warning:...

EU PERSPECTIVES - As Washington retreats from global health financing, the EU is moving to fill the gap. At this week's One Health Summit in Lyon, the European Commission put the first concrete numbers behind its Global Health Resilience Initiative. Three funding commitments — totalling nearly €800 million — mark Europe's bid to lead on global...

EU PERSPECTIVES - Hospitals across Europe are running low on two vital cancer medicines, forcing doctors to make difficult choices about who gets treatment first. Regulators warn that these shortages could last through 2026. Read more

EURACTIV - Speeding up clinical trials must be a central test of the EU's proposed Biotech Act, as Europe risks forfeiting the economic returns on its own scientific breakthroughs, Belgian MEP Wouter Beke has warned. Read more

EURACTIV - Belgium continues to rank among Europe's most active centres for clinical research, yet policymakers in Brussels warn that the country's competitiveness is increasingly strained by a widening gap between cutting‑edge trial activity and the pace at which patients gain access to new therapies. Read more

EU PERSPECTIVES - Medicines that treat cancer or diabetes may be getting more affordable—but cleaning up the water they pollute comes at a cost. The European Commission on Wednesday defended its Urban Wastewater Treatment Directive, rejecting calls from MEPs to pause rules requiring pharmaceutical companies to fund the removal of...

EU PERSPECTIVES - Europe's biotech future is at a crossroads. With €10 billion on the table, the European Commission is racing to show that its funding plans and new incentives will actually drive innovation—before global rivals pull ahead. MEPs are demanding clear evidence that the money will deliver results for both investors and public health. ...

EURACTIV - EU policymaking has become more political, fragmented and increasingly shaped by geopolitical pressure compared with previous mandates, says Sabrine Skiker, Director for Clean Growth at Hanover Communications. Read more